- Home
- HLN vs RLAY Comparison
HLN vs RLAY Comparison
Compare HLN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLN
- RLAY
- Stock Information
- Founded
- HLN 2022
- RLAY 2015
- Country
- HLN United Kingdom
- RLAY United States
- Employees
- HLN N/A
- RLAY N/A
- Industry
- HLN Package Goods/Cosmetics
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLN Consumer Discretionary
- RLAY Health Care
- Exchange
- HLN Nasdaq
- RLAY Nasdaq
- Market Cap
- HLN 41.7B
- RLAY 803.4M
- IPO Year
- HLN N/A
- RLAY 2020
- Fundamental
- Price
- HLN $9.18
- RLAY $7.34
- Analyst Decision
- HLN Hold
- RLAY Strong Buy
- Analyst Count
- HLN 1
- RLAY 8
- Target Price
- HLN N/A
- RLAY $17.25
- AVG Volume (30 Days)
- HLN 9.1M
- RLAY 2.0M
- Earning Date
- HLN 07-31-2025
- RLAY 11-07-2025
- Dividend Yield
- HLN 1.98%
- RLAY N/A
- EPS Growth
- HLN 41.64
- RLAY N/A
- EPS
- HLN 0.23
- RLAY N/A
- Revenue
- HLN $15,096,588,575.00
- RLAY $8,355,000.00
- Revenue This Year
- HLN $1.12
- RLAY $27.30
- Revenue Next Year
- HLN $4.12
- RLAY $7.43
- P/E Ratio
- HLN $40.14
- RLAY N/A
- Revenue Growth
- HLN N/A
- RLAY N/A
- 52 Week Low
- HLN $8.71
- RLAY $1.78
- 52 Week High
- HLN $11.42
- RLAY $7.64
- Technical
- Relative Strength Index (RSI)
- HLN 48.87
- RLAY 67.61
- Support Level
- HLN $9.30
- RLAY $6.30
- Resistance Level
- HLN $9.50
- RLAY $7.64
- Average True Range (ATR)
- HLN 0.12
- RLAY 0.46
- MACD
- HLN 0.00
- RLAY 0.01
- Stochastic Oscillator
- HLN 34.70
- RLAY 83.24
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).